Trial Profile
A Phase III Open-label, Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of StrataGraft Skin Tissue in Promoting Autologous Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements and for Which Excision and Autografts Are Clinically Indicated
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2021
Price :
$35
*
At a glance
- Drugs Human skin replacement (Primary)
- Indications Burns; Skin disorders; Wounds
- Focus Registrational; Therapeutic Use
- Sponsors Stratatech
- 07 Jul 2021 According to a Mallinckrodt Group media release, data from this trial published in Burns, a peer-reviewed journal of the International Society for Burn Injuries.
- 07 Jul 2021 Results presented in a Mallinckrodt media release.
- 15 Jun 2021 Results presented in a Mallinckrodt media release.